Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
- PMID: 23113015
- PMCID: PMC3481750
Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
Abstract
Background: Recent analyses of hospital outbreaks have documented the spread of resistance to imipenem, which is currently a major problem among gram positive and gram-negative bacteria. The aim of this study was to describe the rate of gram-positive and gram-negative isolates resistance to imipenem as an antibiotic.
Methods: Recorded files of 242 hospitalized patients with at least one sample of positive culture specimens in one of the two general hospitals of Shahid Beheshti and Naghavi in Kashan, Iran in 2005 were randomly selected and reviewed. All strains were tested for antibiotic susceptibility by Disk Diffusion and were designated for imipenem.
Results: Escherichia coli (21.9%), Kelebsiella (19.8%) and coagulase-negative Staphylococci (17.8%) were the most common isolated organisms. Imipenem had coverage against 96.2% of Escherichia coli, 58.4% of Kelebsiella, 79.1% of coagulase-negative Staphylococci, 81.8% of Pseudomonas aeruginosa, and 85.7% of Entrococci isolates. Proteus and Salmonella isolates susceptibility to imipenem was 100%.
Conclusion: Susceptibility of Escherichia coli, Salmonella and Proteus to imipenem is satisfactory; however, the susceptibility of Pseudomonas aeruginosa to this antibiotic was dramatically lower in our region. Because of the major health problems caused by imipenem resistance, attempts have been made to organize a national surveillance program in our country.
Keywords: Antibiotic; Bacteria resistance; Imipenem; Pseudomonas.
References
-
- Stratchounski LS, Kozlov RS, Rechedko GK, Stetsiouk OU, Chavrikova EP, Russian NPRS study group Antimicrobial resistance patterns among aerobic gram-negative bacilli isolated from patients in intensive care units: results of a multicenter study in Russia. Clin Microbiol Infect. 1998;4:497–507.
-
- Juan-Torres A, Harbarth S. Prevention of primary bacteraemia. Int J Antimicrob Agents. 2007;30(Suppl 1):S80–7. - PubMed
-
- Bassetti M, Melica G, Cenderello G, Rosso R, Di Biagio A, Bassetti D. Gram-positive bacterial resistance. A challenge for the next millennium. Panminerva Med. 2002;44(3):179–84. - PubMed
-
- Boroumand MA, Esfahanifard P, Saadat S, Sheihkvatan M, Hekmatyazdi S, Saremi M, et al. A report of Pseudomonas aeruginosa antibiotic resistance from a multi-center study in Iran. Indian J Med Microbiol. 2007;25(4):435–6. - PubMed
-
- Bataine HA, Alrashed KM. Resistance gram-negative bacilli and antibiotic consumption in Zarqa, Jordan. Pak J Med Sci. 2007;23(1):59–63.
LinkOut - more resources
Full Text Sources